Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2623-82-7

Post Buying Request

2623-82-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2623-82-7 Usage

Description

2-Bromooctanoic acid is a chemical compound that serves as an effective and cost-efficient substitute for the expensive polyhydroxyalkanoic acid synthesis inhibitor, cerulenin. It is characterized by its ability to block the formation of polyhydroxyalkanoic acid in Pseudomonas fluorescens BM07 without inhibiting cell growth when grown on fructose. Additionally, it exhibits inhibitory effects on the β-oxidation of fatty acids in perfused rat liver and in mitochondria isolated from rat liver.

Uses

Used in Biotechnology Industry:
2-Bromooctanoic acid is used as a polyhydroxyalkanoic acid synthesis inhibitor for [application reason] in the biotechnology industry. It offers a more affordable and less cell-growth-inhibiting alternative to cerulenin, making it a valuable tool for research and development in the field.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-Bromooctanoic acid is used as a research compound for studying the inhibition of fatty acid β-oxidation. Its ability to block this process in rat liver cells makes it a potentially useful agent for investigating metabolic disorders and developing treatments for related conditions.
Used in Chemical Research:
2-Bromooctanoic acid is used as a chemical research tool for understanding the mechanisms behind polyhydroxyalkanoic acid synthesis and fatty acid β-oxidation. Its unique properties allow researchers to explore the interactions between these processes and identify potential targets for therapeutic intervention.

Check Digit Verification of cas no

The CAS Registry Mumber 2623-82-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,6,2 and 3 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 2623-82:
(6*2)+(5*6)+(4*2)+(3*3)+(2*8)+(1*2)=77
77 % 10 = 7
So 2623-82-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H15BrO2/c1-2-3-4-5-6-7(9)8(10)11/h7H,2-6H2,1H3,(H,10,11)

2623-82-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-BROMOOCTANOIC ACID

1.2 Other means of identification

Product number -
Other names Octanoic acid, 2-bromo-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2623-82-7 SDS

2623-82-7Relevant articles and documents

The Stoichiometry and Promoter Role of Chlorosulfuric and Fuming Sulfuric Acids for α-Halogenation of Aliphatic Acid

Ogata, Yoshiro,Watanabe, Shinya

, p. 2417 - 2418 (1980)

The stoichiometry for the chlorosulfuric acid promoted α-halogenation and the role of fuming sulfuric acid instead of chlorosulfuric acid have been studied.In the α-bromination with molecular bromine, 1 mol of halogen afforded 2 mol of aliphatic α-bromo acid just as the α-iodination, but it is different from α-chlorination which affords only 1 mol of α-chloro acid.Fuming sulfuric acid instead of chlorosulfuric acid was found to be effective for α-bromination, but the yield was lower, while no α-iodination was observed with fuming sulfuric acid.

Enantioselective construction of tetrasubstituted stereogenic carbons through bronsted base catalyzed michael reactions: α′-hydroxy enones as key enoate equivalent

Badiola, Eider,Fiser, Bla,Gmez-Bengoa, Enrique,Mielgo, Antonia,Olaizola, Iurre,Urruzuno, Iaki,Garca, Jess M.,Odriozola, Jos M.,Razkin, Jess,Oiarbide, Mikel,Palomo, Claudio

supporting information, p. 17869 - 17881 (2015/02/19)

Catalytic and asymmetric Michael reactions constitute very powerful tools for the construction of new C-C bonds in synthesis, but most of the reports claiming high selectivity are limited to some specific combinations of nucleophile/electrophile compound types, and only few successful methods deal with the generation of all-carbon quaternary stereocenters. A contribution to solve this gap is presented here based on chiral bifunctional Bronsted base (BB) catalysis and the use of α′-oxy enones as enabling Michael acceptors with ambivalent H-bond acceptor/donor character, a yet unreported design element for bidentate enoate equivalents. It is found that the Michael addition of a range of enolizable carbonyl compounds that have previously demonstrated challenging (i.e., α-substituted 2-oxindoles, cyanoesters, oxazolones, thiazolones, and azlactones) to α′-oxy enones can afford the corresponding tetrasubstituted carbon stereocenters in high diastereo- and enantioselectivity in the presence of standard BB catalysts. Experiments show that the α′-oxy ketone moiety plays a key role in the above realizations, as parallel reactions under identical conditions but using the parent α,β-unsaturated ketones or esters instead proceed sluggish and/or with poor stereoselectivity. A series of trivial chemical manipulations of the ketol moiety in adducts can produce the corresponding carboxy, aldehyde, and ketone compounds under very mild conditions, giving access to a variety of enantioenriched densely functionalized building blocks containing a fully substituted carbon stereocenter. A computational investigation to rationalize the mode of substrate activation and the reaction stereochemistry is also provided, and the proposed models are compared with related systems in the literature.

N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors

-

, (2008/06/13)

Matrix metalloproteinases (MMPs) are a group of enzymes that have been implicated in the pathological destruction of connective tissue and basement membranes. These zinc containing endopeptidases consist of several subsets of enzymes including collagenases, stromelysins and gelatinases. TNF-α converting enzyme (TACE), a pro-inflammatory cytokine, catalyzes the formation of TNF-α from membrane bound TNF-α precursor protein. It is expected that small molecule inhibitors of MMPs and TACE therefore have the potential for treating a variety of disease states. The present invention provides low molecular weight, non-peptide inhibitors of matrix metalloproteinases (MMPs) and TNF-α converting enzyme (TACE) for the treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and HIV infection having the formula wherein R2and R3form a heterocyclic ring and A is S, S(O), or S(O)2, and R1and R4are defined herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2623-82-7